ZKB/CALL/ROCHE GS/350/0.01/06.01.25 Share Price

Warrant

ROGJXZ

CH1235752925

Real-time Bid/Ask 09:04:04 26/06/2024 BST
0.005 CHF / 0.015 CHF 0.00% Intraday chart for ZKB/CALL/ROCHE GS/350/0.01/06.01.25
Current year-50.00%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer ZKB
ROGJXZ
ISINCH1235752925
Date issued 06/01/2023
Strike 350 CHF
Maturity 06/01/2025 (194 Days)
Parity 100 : 1
Emission price 0.1 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 0.095 CHF
Lowest since issue 0.01 CHF
Spread 0.01 CHF
Spread %66.67%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
253.4 CHF
Average target price
278.1 CHF
Spread / Average Target
+9.73%
Consensus
  1. Stock Market
  2. Warrants
  3. ROGJXZ Warrant